Technopath Clinical Diagnostics Introduces the First Unified, Purpose-Built Quality Control (QC) Platform Providing a Higher Level of Confidence
Technopath Clinical Diagnostics Introduces the First Unified, Purpose-Built Quality Control (QC) Platform Providing a Higher Level of Confidence in the Precision and Accuracy of Patient Sample Results
PR85863
NEW YORK and BALLINA, Ireland, Oct. 1, 2020 /PRNewswire=KYODO JBN/ --
- IAMQC Infinity(TM) is the first Software-as-a-Service (SaaS) platform for
clinical laboratories to bring together worldwide peer comparisons, advanced QC
analytics, proficiency testing data, and daily QC data management functions in
real-time on one unified platform
- IAMQC Infinity empowers frontline laboratory staff to spend less time on
false-positive QC flags while concentrating on tests that require their attention
- IAMQC web-based technology, unified with Infinity's open system flexibility
to optimize all QC data generated in the lab, delivers higher confidence in
analytical testing methods while significantly reducing time, effort, and costs
Technopath, a leading global provider of SaaS-based QC data management
solutions and third-party laboratory quality controls, today introduced IAMQC
Infinity to support the growing need from modern laboratories for robust
management of overall quality control and proficiency testing. Based on these
challenges, IAMQC Infinity significantly improves operational efficiencies
through a unified QC technology platform bringing people, systems, and data
together to form a collaborative, efficient, and effective ecosystem that
analyses QC results in real-time.
Laboratory testing of patient samples can be complicated, and QC represents one
of the most important impacts on laboratory testing as it ensures both the
precision and accuracy of patient sample results. The integrity of quality control
samples is essential, and IAMQC Infinity delivers higher confidence in analytical
testing methods satisfying the varying QC requirements in individual laboratories.
"With quality control data growing, and the management of that QC data
increasing in complexity, our focus is on innovating and developing the
best-in-class QC solutions platform for the laboratory community," said Malcolm
Bell, CEO and founder of Technopath. "Modern laboratories have many constraints
in their daily processes underscored by a rapidly changing requirement to
quickly review current or historical data by lab, department, instrument or
test. Optimizing and managing QC data is imperative, and the Infinity platform
is purpose-built to capture and evaluate these constantly evolving data types
allowing laboratorians to have greater confidence that their patient testing is
producing accurate results."
IAMQC Infinity is an easy-to-use, cost-effective platform built on a highly
scalable SaaS architecture, allowing users to automate, centralize, standardize
and improve QC processes, eliminating the need for manual entry by skilled
laboratory technologists. Infinity brings all the key elements of powerful
cloud-based software tools to analyze QC results into one web-based solution.
With pressures increasing on the laboratory to turn around fast, accurate
patient results, the new platform will include three feature-rich tools
designed to facilitate the entire quality control process from end to end:
IAMQC Peer - an innovative, real-time, peer comparison helping laboratories
validate their QC protocols including the proliferation of new instruments,
methods, and tests.
IAMQC Daily - a comprehensive internal quality control software that applies
Westgard or any user-defined QC rules to individual QC results.
IAMQC Expert - an interactive system that empowers frontline laboratory staff
to select QC rules, reduce unnecessary repeats, and make meaningful QC decisions.
Modern laboratories are becoming increasingly reliant on real-time, independent
QC data to make timely and informed decisions. The latest IAMQC updates bring
more substantial analytics capabilities, allowing laboratories to turn data
points into meaningful insights. The system is easy to set up, and removes
obstacles such as server installation, based on customer feedback including
Northwell Hospital, New York's largest healthcare provider.
IAMQC Infinity platform is rolling out globally in two phases:
Phase 1 rollout is now live and includes the critical functions required for
IAMQC Daily such as rule evaluation, tracking of actions and comments, and
custom rule set configuration.
Phase 2 will deploy several solutions that include built-in peer comparison
functionality and reports and advanced QC analysis tools such as Total Error
calculations and problem solver wizards. These follow up releases will be
scheduled to launch in Q2, 2021.
About IAMQC
[https://www.technopathclinicaldiagnostics.com/products/informatics-solutions/ov
erview-software-solutions/ ]
For more about Technopath please visit:
https://www.technopathclinicaldiagnostics.com/about/our-company/
Logo - https://mma.prnewswire.com/media/1165846/Technopath_Logo.jpg
For Media:
Sunny Uberoi
Corporate Communications
Telephone: +1-917-747-2018
Email: sunny@166media.com
For Business Development:
Conor Connolly
VP Commercial, Technopath Clinical Diagnostics
Email: conor.connolly@technopathcd.com
For Business Development USA:
Todd Leger
CEO Technopath Clinical Diagnostics USA Inc
Email: todd.leger@technopathusa.com
For Marketing & Communications:
Len Lloyd
Director Marketing, Technopath Clinical Diagnostics
Email: len.lloyd@technopathcd.com
Source: Technopath Clinical Diagnostics
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。